ASC_logo_black.jpg
Appointment of Ben Vertannes as Head of Global Marketing
08 mars 2021 02h00 HE | Ascension
PRESS RELEASE Appointment of Ben Vertannes as Head of Global Marketing LONDON, March 8, 2021 – Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage pharmaceutical company...
Pregnant Patients Should Weigh Risk of COVID Jab, States Association of American Physicians and Surgeons (AAPS)
04 mars 2021 13h39 HE | Association of American Physicians and Surgeons
TUCSON, Ariz., March 04, 2021 (GLOBE NEWSWIRE) -- The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) have recommended that COVID-19...
Pfizer und BioNTech
Pfizer und BioNTech beginnen Studie mit COVID-19-Auffrischungsimpfung und neuen Impfstoffvarianten als Teil eines umfassenden Entwicklungsplans
25 févr. 2021 06h45 HE | BioNTech SE
Die Verabreichung einer dritten Dosis des Pfizer-BioNTech COVID-19-Impfstoffs BNT162b2 wird als Teil der Phase-1/2/3-Studie untersucht; die Teilnehmer der Phase-1-Studie erhalten eine 30µg-Dosis...
Pfizer and BioNTech
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
25 févr. 2021 06h45 HE | BioNTech SE
The evaluation is part of the Phase 1/2/3 trial and will study a third dose of the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, at 30 µg that will be given to Phase 1 participants to evaluate the...
logo-alt.png
Global Rare Disease Market is estimated to be US$ 547.5 billion by 2030 with a CAGR of 13.1% during the forecast period - by PMI
24 févr. 2021 10h35 HE | PMI
Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Global Rare Disease Market accounted for US$ 161.4 billion in 2020 and is estimated to be US$ 547.5 billion by 2030 and is anticipated to register a CAGR...
logo-alt.png
Global Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR of 2.7% during the forecast period - by PMI
24 févr. 2021 10h05 HE | PMI
Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global schizophrenia drug market accounted for US$ 7.5 Bn in 2020 and is estimated to be US$ 9.8 Bn by 2030 and is anticipated to register a CAGR of...
Pfizer und BioNTech
Pfizer und BioNTech reichen Stabilitätsdaten zur Lagerung des COVID-19-Impfstoffs bei Standard-Gefriertemperaturen bei der U.S.-amerikanischen FDA ein
19 févr. 2021 07h07 HE | BioNTech SE
Vorgeschlagenes Etiketten-Update in den USA würde die Lagerung des Impfstoffs für zwei Wochen bei -25°C bis -15°C (-13°F bis 5°F) ermöglichenFalls genehmigt, könnte die neue Lagerungsmöglichkeit...
Pfizer and BioNTech
Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
19 févr. 2021 07h07 HE | BioNTech SE
Proposed U.S. EUA label update would enable the vaccine to be stored at -25°C to -15°C (-13°F to 5°F) for a total of two weeks If approved, new storage option could offer pharmacies and vaccination...
Pfizer und BioNTech
Pfizer und BioNTech starten globale klinische Studie zur Untersuchung des COVID-19-Impfstoffs in schwangeren Frauen
18 févr. 2021 13h30 HE | BioNTech SE
Phase-2/3-Studie wird ca. 4.000 gesunde, schwangere Frauen in den USA, Kanada, Argentinien, Brasilien, Chile, Mosambik, Südafrika, dem Vereinigten Königreich und Spanien umfassenErste Teilnehmerinnen...
Pfizer and BioNTech
Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
18 févr. 2021 13h30 HE | BioNTech SE
Phase 2/3 trial will enroll approximately 4,000 healthy pregnant women in the U.S., Canada, Argentina, Brazil, Chile, Mozambique, South Africa, U.K., and SpainFirst participants dosed in the U.S....